====== Zymeworks ======

{{ :pharmaceutical_companies:zymeworks_logo_color.jpeg?200|}}

**Zymeworks** is a Canadian biotechnology company based in [[canada:british_columbia:Vancouver]], [[canada:British Columbia]]. The company develops [[:protein]] [[:therapeutics]] for the treatment of [[:cancer]] as well as for [[:autoimmune diseases|autoimmune]] and [[:inflammatory diseases]].

===== Affiliations =====

In 2011, [[Merck]] entered an agreement with Zymeworks to use their Azymetric™ platform for the development and commercialization of bispecific antibodies against targets in multiple therapeutic fields.((//Merck & Co. Seals Bispecific Antibody Collaboration with Zymeworks.// (2011, August 29). GEN - Genetic Engineering and Biotechnology News. https://archive.ph/f4CA2)) The arrangement involved the joint development and improvement of the platform, as well as Merck taking the resulting novel antibody products through clinical development.((//FOI Request - HTH-2015-51828.// (2016, February 12). Government of British Columbia. https://web.archive.org/web/20220428045844/http://docs.openinfo.gov.bc.ca/Response_Package_HTH-2015-51828.pdf))

===== External links =====

  * [[https://wiki.whiteroseintelligence.com/en/Zymeworks|White Rose Wiki]]